Cargando…

Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome

Most hospitals are facing the dilemma caused by demand for critical care beds outstripping supply. This imbalance is likely to get worse over the coming years as a result of many factors, including aging of the population, improved technology, and improved therapies, among other factors. As a result...

Descripción completa

Detalles Bibliográficos
Autores principales: Crippen, David, Hawryluck, Laura
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522828/
https://www.ncbi.nlm.nih.gov/pubmed/15312204
http://dx.doi.org/10.1186/cc2823
_version_ 1782121856318308352
author Crippen, David
Hawryluck, Laura
author_facet Crippen, David
Hawryluck, Laura
author_sort Crippen, David
collection PubMed
description Most hospitals are facing the dilemma caused by demand for critical care beds outstripping supply. This imbalance is likely to get worse over the coming years as a result of many factors, including aging of the population, improved technology, and improved therapies, among other factors. As a result we are likely to have to make further tough decisions about rationing of this service. In this issue of Critical Care, two authors debate the appropriateness of providing life support in accordance with a family's wishes to an individual who is unlikely to survive admission to the intensive care unit. Understanding both sides of this debate is an important aspect of an intensivist's job.
format Text
id pubmed-522828
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5228282004-10-17 Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome Crippen, David Hawryluck, Laura Crit Care Review Most hospitals are facing the dilemma caused by demand for critical care beds outstripping supply. This imbalance is likely to get worse over the coming years as a result of many factors, including aging of the population, improved technology, and improved therapies, among other factors. As a result we are likely to have to make further tough decisions about rationing of this service. In this issue of Critical Care, two authors debate the appropriateness of providing life support in accordance with a family's wishes to an individual who is unlikely to survive admission to the intensive care unit. Understanding both sides of this debate is an important aspect of an intensivist's job. BioMed Central 2004 2004-02-19 /pmc/articles/PMC522828/ /pubmed/15312204 http://dx.doi.org/10.1186/cc2823 Text en Copyright © 2004 BioMed Central Ltd
spellingShingle Review
Crippen, David
Hawryluck, Laura
Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
title Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
title_full Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
title_fullStr Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
title_full_unstemmed Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
title_short Pro/con clinical debate: Life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
title_sort pro/con clinical debate: life support should have a special status among therapies, and patients or their families should have a right to insist on this treatment even if it will not improve outcome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522828/
https://www.ncbi.nlm.nih.gov/pubmed/15312204
http://dx.doi.org/10.1186/cc2823
work_keys_str_mv AT crippendavid proconclinicaldebatelifesupportshouldhaveaspecialstatusamongtherapiesandpatientsortheirfamiliesshouldhavearighttoinsistonthistreatmentevenifitwillnotimproveoutcome
AT hawrylucklaura proconclinicaldebatelifesupportshouldhaveaspecialstatusamongtherapiesandpatientsortheirfamiliesshouldhavearighttoinsistonthistreatmentevenifitwillnotimproveoutcome